Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumour necrosis factor (TNF) receptor J Malejczyk"2, M Malejczyk23, F Breitburd3, S Majewski2'3, A Schwarz4, N Expert-Besanson5, S Jablonska3, G Orth2 and TA Luger4 Keywords: tumour necrosis factor; soluble tumour necrosis factor receptor; tumour cell growth; human papillomavirus Certain types of human papillomaviruses (HPVs) are known to be associated with intraepithelial neoplasia of the cervix and external genitalia (Jenson and Lancaster, 1990; Kiviat and Koutsky, 1993) . These lesions usually display a slow, self-limited growth and frequently regress, either spontaneously or after treatment. However, some persisting lesions induced by 'high-risk' HPV types e.g. HPV 16, 18, 31 and 33, may evolve into invasive carcinomas (zur Hausen, 1989; Howley, 1991) . The evidence accumulates that growth and dissemination of HPV-associated lesions are under control of local and/or systemic immune surveillance (Jablonska et Pfister, 1990) . Especially, local production of immunoregulatory anti-tumour cytokines, e.g. TNF-a, IL-6 and TGF-f1, may play an important role. These cytokines were shown to be expressed by HPV-harbouring keratinocytes and may directly or indirectly affect growth of the transformed cells (Woodworth et al., 1990; Majewski et al., 1991; Malejczyk et al., 1991 Malejczyk et al., , 1992 . Accordingly, a non-tumorigenic SKv keratinocyte cell line established from vulvar intraepithelial neoplasia and harbouring and expressing integrated HPV16 DNA sequences (Schneider-Maunoury et al., 1987; 1990) has been found to release TNF-a spontaneously which in turn exerted an autocrine growth inhibitory effect (Malejczyk et al., 1992) . These results strongly suggest the existence of an autocrine TNF-amediated mechanism which could be, at least partially, responsible for self-limited growth and eradication of certain HPV-associated tumours.
Certain types of human papillomaviruses (HPVs) are known to be associated with intraepithelial neoplasia of the cervix and external genitalia (Jenson and Lancaster, 1990; Kiviat and Koutsky, 1993) . These lesions usually display a slow, self-limited growth and frequently regress, either spontaneously or after treatment. However, some persisting lesions induced by 'high-risk' HPV types e.g. HPV 16, 18, 31 and 33, may evolve into invasive carcinomas (zur Hausen, 1989; Howley, 1991) . The evidence accumulates that growth and dissemination of HPV-associated lesions are under control of local and/or systemic immune surveillance (Jablonska et al., 1989; Pfister, 1990) . Especially, local production of immunoregulatory anti-tumour cytokines, e.g. TNF-a, IL-6 and TGF-f1, may play an important role. These cytokines were shown to be expressed by HPV-harbouring keratinocytes and may directly or indirectly affect growth of the transformed cells (Woodworth et al., 1990; Majewski et al., 1991; Malejczyk et al., 1991 Malejczyk et al., , 1992 . Accordingly, a non-tumorigenic SKv keratinocyte cell line established from vulvar intraepithelial neoplasia and harbouring and expressing integrated HPV16 DNA sequences (Schneider-Maunoury et al., 1987; 1990) has been found to release TNF-a spontaneously which in turn exerted an autocrine growth inhibitory effect (Malejczyk et al., 1992) . These results strongly suggest the existence of an autocrine TNF-amediated mechanism which could be, at least partially, responsible for self-limited growth and eradication of certain HPV-associated tumours.
Progressive growth and dissemination of HPV-induced lesions may be, at least partially, related to escape from local cytokine-mediated surveillance. Indeed, highly tumorigenic HPV-harbouring epithelial cells have been found to be resistant to anti-proliferative activity of TGF-,B (Woodworth et al., 1990; Braun et al., 1990) . Similarly, spontaneous tumorigenic progression of SKv cells was found to be associated with loss of susceptibility to autocrine TNFa-mediated growth limitation (Malejczyk et al., 1994) . This phenomenon was, at least partially, related to a lowered type I TNF receptor (TNF-RI) expression, however, it could also depend on release of some TNF-cx inhibitory activity. Therefore, the aim of the present study was to investigate whether increased proliferation and tumorigenicity of SKv cells are associated with an ability to release TNF inhibitory factor(s).
Materials and methods Reagents
Recombinant human TNF-a (rhTNF-a; specific activity 2 x 107 U mg-') was generously provided by BASF/Knoll (Ludwigshafen, Germany) and recombinant human TNF-,B (rhTNF-fl; specific activity 3 x 107 U mg-1) was purchased from Genzyme (Boston, MA, USA 2) at flow rate 1 ml min-1 and 0.5 ml fractions were collected. Column fractions were diluted with culture medium and kept frozen until used for further determinations.
Evaluation of TNF inhibitory activity TNF inhibitory activity in FPLC fractions was evaluated in the presence of 5 U ml-1 of rhTNF-cx or rhTNF-,B using a conventional TNF bioassay with actinomycin-D-treated L929 cells (Kramer and Carver, 1986) . The activity of the inhibitor was expressed in neutralising units (NU), where 1 NU was defined as the highest dilution of the tested material sufficient to neutralise cytotoxic activity exerted by 1 U of TNF-a or TNF-,B.
Northern blot analysis The cells were lysed in 4 M guanidine isothiocyanate containing 0.1 M 2-mercaptoethanol (2-ME) and total RNA was isolated over a caesium chloride cushion. RNA samples were then separated by a gel electrophoresis in 1% agarose under denaturing conditions, transferred onto nitrocellulose membranes and prehybridised as described previously (Malejczyk et al., 1992) . For detection and characterisation of soluble TNF-R, the SKv cell-CM was extensively dialysed, lyophylised and subjected to SDS-PAGE under reducing conditions as described (Malejczyk et al., 1992) . Separated proteins were blotted onto nitrocellulose paper (Bio-Rad) and the TNF-RI and TNF-RII were detected with htr-9 and utr-1 MAb respectively, followed by amplified alkaline phosphatase detection system (Bio-Rad).
Evaluation of sTNF-R The presence of soluble forms of TNF-RI and TNF-RII in conditioned media taken from SKv cell cultures after different periods of time was detected and evaluated by specific enzyme-linked immunobiological assay (ELIBA) (generously donated by Drs N Drees and H Galatti of F Hoffmann-La Roche, Basle, Switzerland). The assays were performed according to the attached manufacturer's protocols.
Results

Detection of SKv cell-derived TNF inhibitory activity
The presence of TNF-ox/TNF-# inhibitory activity in CM generated in 48 h culture of SKv-12 cells was demonstrated by FPLC gel filtration followed by L929 cytotoxicity assay (Figure 1) probe showed that both SKv-Il and SKv-12 cells expressed a single 2.5 kb species of specific mRNA. In line with our previous observation (Malejczyk et al., 1994) , the levels of specific steady-state mRNA were higher in SKv-Il than in SKv-12 cells. This difference was not caused by an unequal amount of RNA loaded onto each lane in as much as rehybridisation with ,B-actin cDNA probe showed similar amounts of specific ,B-actin mRNA. Similarly, radioimmunoprecipitation of TNF-RI from SKv-11 and SKv-12 cell extracts with htr-9 MAb also revealed only a single specific band corresponding to Mr of 55 000 (Figure 2b ). The amount of TNF-RI was slightly higher in SKv-11 cells.
Neutralisation of SKv-1 cell-derived TNF inhibitory activity by htr-9 MAb strongly suggested that it may be related to sTNF-RI. Therefore, the presence of sTNF-RI in SKv cell-CM was evaluated by the Western blot method and specific ELIBA. Indeed, Western blot analysis of SKv-Il and SKv-12 cell-CM showed the presence of a single htr-9-immunoreactive band corresponding to Mr of 31 500 ( Figure  2c ). The intensity of the band was significantly higher in the case of SKv-12 cells. Spontaneous production of sTNF-RI by SKv-1 cells was further demonstrated by the specific ELIBA (Figure 3) . Evaluation of the kinetics of sTNF-RI release by SKv-1 cells showed that the amount of the factor increased with time of culture reaching a plateau after 48 h. In accord with the results obtained by the Western blot method, there were significant differences (at least at P < 0.01 by Wilcoxon's test) in sTNF-RI release between highly tumorigenic SKv-12 cells and their weakly tumorigenic SKv-11 parental cells. SKv-12 cells released about 2-fold more sTNF-RI than SKv-il cells (Figure 3) .
Neither the specific TNF-RII mRNA nor TNF-RII protein were detected in SKv-1 cells or SKv-1 cell-CM by Northern blot, radioimmunoprecipitation, Western blot or specific ELIBA (data not shown).
Effect of sTNF-R on proliferation of SKv cells
Compared with weakly tumorigenic SKv-11 parental cells, SKv-12 cells displayed a significantly higher in vitro proliferative potential which correlated with their increased tumorigenic potential (Malejczyk et al., 1994) . To evaluate whether the higher proliferation of SKv-I cells may be related to some stimulatory activity of sTNF-RI, both SKv-11 and SKv-12 cells were cultured in the presence of different (1) and (2) concentrations of rhsTNF-RI. As seen in Figure 4 , rhsTNF-RI exerted a significant (P < 0.01 by non-parametric Wilcoxon test) dose-dependent stimulatory effect on the growth of weakly tumorigenic TNF-sensitive SKv-i cells.
On the other hand, it did not significantly affect the proliferation of highly tumorigenic SKv-12 cells. Heatinactivated rhsTNF-RI influenced proliferation of neither SKv-i nor SKv-12 cells. FPLC-enriched preparation of SKv cell-derived sTNF-RIrelated TNF inhibitor stimulated proliferation of SKv-11 cells in a similar way and to a similar extent as rhsTNF-RI (data not shown).
Discussion
The results of the present study show that HPV16-harbouring SKv keratinocytes spontaneously released a factor that protected L929 cells from the cytotoxic activity of both TNF-a and TNF-fl. TNF inhibitory molecules have previously been found in the sera and urine of normal and febrile patients and were identified as soluble forms of TNF-R Lantz et al., 1990; Seckinger et al., 1990) . TNF inhibitory activity of SKv cell-derived factor was specifically neutralised by htr-9 MAb recognising human TNF-RI. This strongly suggests that SKv cell-derived TNF inhibitor is also related to sTNF-RI.
Release of sTNF-RI by SKv-1 cells was confirmed by Western blot analysis and specific ELIBA. Upon FPLC gel filtration SKv cell-derived TNF inhibitor displayed a molecular weight of about 25-35 kDa, and Western blot analysis with TNF-RI-specific htr-9 MAb has revealed a single band of 31.5 kDa. This is in agreement with previous findings on urine-derived sTNF-R as well as sTNF-R released by cells transfected with full-length TNF-R cDNA showing that these molecules display a molecular weight in the range of 27-40 kDa (Engelmann et al., 1989; Kohno et al., 1990; Seckinger et al., 1990) . Since only a single major species of specific TNF-R mRNA could be identified in normal and TNF-R cDNA transfected cells (Gray et al., 1990; Kohno et al., 1990; Nophar et al., 1990) , it is plausible that these sTNF-R originated from shedding of the membrane-bound receptor. Similarly, Northern blot analysis of mRNA isolated from SKv cells showed a single signal corresponding to full-length TNF-RI mRNA. Immunoprecipitation of whole SKv cellular extracts with htr-9 MAb also revealed only one band corresponding to an intact 55 kDa Figure 4 Effect of normal (-) and heat-inactivated (----) rhsTNF-RI on proliferation of weakly tumorigenic and highly tumorigenic The mechanism responsible for spontaneous shedding of sTNF-RI by SKv cells remains unclear. Shedding of sTNF-R was found to be induced by various exogenous stimulatory agents such as phorbol esters, N-formyl Met-Leu-Phe, CSa, GM-CSF and anti-CD3 MAb and requires endogenous protein kinase activity (Gray et al., 1990; Porteu and Nathan, 1990; Crowe et al., 1993) . It is plausible that it results from some proteolytic cleavage of cell-bound TNF-R (Nophar et al., 1990) , and, in the case of release of sTNF-RII from neutrophils, an elastase is a possible candidate (Porteu et al., 1991) .
Highly tumorigenic SKv-12 cells released significantly more sTNF-RI than their weakly tusnorigenic SKv-1I parental cells. In as much as the amount of the steady-state TNF-RI mRNA and cell-bound TNF-RI protein in SKv-12 cells were found to be significantly lower than in SKv-11 cells, this phenomenon cannot be explained simply as being related to a higher level of TNF-RI expression by SKv-12 cells. The malignant phenotype of a variety of neoplastic cells is associated with increased endogenous protein kinase activity and an excessive release of proteolytic enzymes (Strauli et al., 1980; Bishop, 1991) . Accordingly, an increased release rate of sTNF-RI might be caused by a higher protein phosphorylation rate and/or extracellular protease activity associated with the more malignant phenotype of SKv-12 cells. However, a putative protease that could be responsible for releasing the sTNF-RI from SKv cells is unknown.
Spontaneous release of sTNF-R/TNF inhibitor has been observed in some tumour cell lines (Aderka et al., 1991) . Furthermore, significantly increased levels of sTNF-R were detected in the sera of patients with various neoplastic diseases (Aderka et al., 1991; Waage et al., 1992) . Physiological and immunopathological significance of this phenomenon is unknown. However, it is tempting to speculate that sTNF-R may exert a tumour protecting effect: (1) shedding of surface-bound TNF-R from tumour cells may lead to their desensitisation to circulating TNF, and (2) sTNF-R may neutralise biological anti-tumour activity of the locally released TNF. Accordingly, release of higher amounts of sTNF-RI by highly tumorigenic SKv-12 cells was accompanied by their higher in vitro proliferation and correlated with their relative TNF-resistance and higher tumorigenic potential (Malejczyk et al., 1994) . Furthermore, treatment of weakly tumorigenic, TNF-sensitive SKv-l 1 parental cells with rhsTNF-RI or SKv cell-derived TNF inhibitor resulted in a significant dosedependent stimulation of their growth. This effect was specific and heat-inactivation of rhsTNF-RI resulted in loss of its growth stimulatory effect on SKv-l 1 cells. In as much as SKv cells spontaneously express and release TNFE-which, in turn, exerts an autocrine anti-proliferative effect (Malejczyk et al., 1992) , the stimulatory effect of sTNF-RI on SKv-l 1 cells may be explained as caused by neutralisation of the endogenous cytokine. Thus, it is plausible that an increased proliferative potential and high tumorigenicity of SKv-12 cells may be, at least partially, related to an excessive release of sTNF-RI. These results strongly support a view that sTNF-R may enable tumour cell escape from local TNF-z-mediated surveillance and may be one of the important factors facilitating progressive growth of certain neoplastic lesions. Abbrevaloms CM, conditioned medium; ELIBA, enzyme-linked immunobiological assay; FPLC, fast protein liquid chromatography; HPV, human papillomavirus; MAb, monoclonal antibody; NU, neutralising unit; sTNF-R, soluble tumour necrosis factor receptor.
